VI

Biotechnology

Jobs at Vividion Therapeutics, Inc.

About Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.

Industry
Biotechnology
Open roles
5

Open positions

Explore roles at Vividion Therapeutics, Inc.

Showing 5 of 5 roles

San Diego, United States·On-Site·Contract
VI

Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.

San Diego, United States·On-Site·Full-time
VI

Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.

San Diego, United States·On-Site·Full-time
VI

Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.

San Diego, United States·On-Site·Full-time
VI

Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.

San Diego, United States·On-Site·Full-time
VI

Vividion Therapeutics, Inc.

Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.